1 year return (CAGR)
59.87%
Propanc Biopharma, Inc. Common Stock Exchange (NASDAQ, USD)
PPCB
2.43
+0.14 (+6.11%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-88.95%
5 year return (CAGR)
-93.39%
10 year return (CAGR)
-87.17%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
15.38M
Price/Sales
-
Ent value
17.93M
Price/Book
1.64
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-16.09%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-84.91%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.24 |
| Daily high | 2.47 |
| Daily low | 2.21 |
| Daily Volume | 44K |
| All-time high | 999999999900.00 |
| 1y analyst estimate | 1.52 |
| Beta | 3.33 |
| EPS (TTM) | -5.70 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PPCB | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.21% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 27 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -84.43% | -10.65% |
| Avg time to new high | 8 days | 12 days |
| Max time to new high | 2369 days | 1805 days |
News
